"At Hospital for Special Care, we rebuild lives. Hospital for Special Care provides an acclaimed spectrum of medical treatment for complex rehabilitation and chronic disease for both children and adults augmented by a range of outpatient rehabilitative services. For people with disabilities, Hospital for Special Care has made a special commitment to assure that they strive to achieve their fullest physical and recreational potential."

During the past decade, Hospital for Special Care conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 10 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital for Special Care" #1 sponsor was "Cytokinetics" with 7 trials, followed by "Flex Pharma, Inc." with 2 trials sponsored, "Knopp Biosciences" with 2 trials sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored and "Acorda Therapeutics" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital for Special Care" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "ALS Association" with 1 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Hospital for Special Care" are "Amyotrophic Lateral Sclerosis" (10 trials), "Amyotrophic Lateral Sclerosis (ALS)" (2 trials), "Charcot-Marie-Tooth Disease" (2 trials), "ALS" (1 trials) and "Chronic Obstructive Pulmonary Disease (COPD)" (1 trials). Many other conditions were trialed in "Hospital for Special Care" in a lesser frequency.

Most popular intervention types in "Hospital for Special Care" are "Drug" (19 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "CK-2017357" (2 trials), "CNM-Au8" (2 trials), "Dexpramipexole" (2 trials) and "FLX-787-ODT (orally disintegrating tablet)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital for Special Care" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Hospital for Special Care". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Hospital for Special Care, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital for Special Care, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".